Search | IOVS | ARVO Journals

Showing 1 – 20 of 92

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Extending interoperability in ophthalmology through Fast Healthcare Interoperability Resource (FHIR)

Ashley Kras; Warren Oliver; Mark C Gillies; Michael Mair; Stephen Chu; Nigel Morlet; Michael Mbagwu; Thomas S Hwang; Matthew Roe; Theordore Leng

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1708. doi:

ARVO Annual Meeting Abstract June 2021

Disruption of the pentose phosphate pathway in Müller cells makes them more susceptible to light stress by interfering with the oxidative stress-induced NRF2 response

Yingying Chen; Ting Zhang; Shaoxue Zeng; Kaiyu Jin; Rong Xu; Xiaohui Fan; Meixia Zhang; Jianhai Du; Mark C Gillies; Ling Zhu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1667. doi:

ARVO Annual Meeting Abstract June 2021

JR5558 transgenic mice are a reliable model to investigate subretinal fibrosis

Yashar Seyed-Razavi; So-Ra Lee; Jiawen Fan; Weiyong Shen; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2253. doi:

ARVO Annual Meeting Abstract June 2021

Quality of life impact of eye diseases: a Save Sight Registries study

Himal Kandel; Vuong Nguyen; Mark C Gillies; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3495. doi:

ARVO Annual Meeting Abstract June 2021

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Javier Zarranz-Ventura; Vuong Nguyen; Catherine P Creuzot Garcher; Frank D Verbraak; Louise OToole; Alessandro Invernizzi; Francesco Viola; David Squirrell; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):311. doi:

ARVO Annual Meeting Abstract June 2021

Variation in visual outcomes for neovascular age-related macular degeneration within and between practitioners

Vuong Nguyen; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):455. doi:

ARVO Annual Meeting Abstract June 2020

Comparison of glucose metabolism in human macula and peripheral retina

Ting Zhang; Shaoxue Zeng; Michele C Madigan; Meidong Zhu; Jianhai Du; Weiyong Shen; Ling Zhu; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3539. doi:

ARVO Annual Meeting Abstract June 2020

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Mark C Gillies; Vuong Nguyen; Calvo Pilar; Martin Puzo; Pierre-Henry GABRIELLE; Catherine P Creuzot Garcher; Florian Baudin; Benjamin Wolff; Louise O’ Toole; Laurent Castelnovo; Michel Guillaume; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4214. doi:

ARVO Annual Meeting Abstract June 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

SANJEEB BHANDARI; Vuong Nguyen; Samantha Fraser-Bell; Hemal Mehta; Francesco Viola; Florian Baudin; Pierre-Henry Gabrielle; Catherine P Creuzot Garcher; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3289. doi:

ARVO Annual Meeting Abstract June 2020

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Rishi P Singh; Robin Hamilton; Jeffrey S Heier; Carl Regillo; Mark C Gillies; Georges Weissgerber; Jahangir Alam; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1158. doi:

ARVO Annual Meeting Abstract June 2020

Towards retinal regeneration: Reprogramming retinal glial cells into photoreceptors using CRISPRa

Raymond Wong; Tu Nguyen; Lyujie Fang; Sam Lukowski; Camden Lo; Sandy Hung; Chi D Luu; Mark C Gillies; Alex W Hewitt

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2497. doi:

ARVO Annual Meeting Abstract June 2020

PD98059 inhibits the activation of mitogen-activated protein kinase in stressed Müller cells and protects photoreceptor from degeneration

Shaoxue Zeng; Ting Zhang; Michele C Madigan; Riccardo Carlo Natoli; Junjun Zhang; Nilisha Fernando; Joshua Aaron Chu-Tan; Ling Zhu; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3219. doi:

Genetics September 2019

MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus

PDF

Ebony Liu; Georgia Kaidonis; Bennet J. McComish; Mark C. Gillies; Sotoodeh Abhary; Rohan W. Essex; John H. Chang; Bishwanath Pal; Mark Daniell; Stewart Lake; Nikolai Petrovsky; Alex W. Hewitt; Alicia Jenkins; Ecosse L. Lamoureux; Jonathan M. Gleadle; Jamie E. Craig; Kathryn P. Burdon
TAGS: diabetes mellitus, type 1, diabetic retinopathy, genes, genetics, micrornas, single nucleotide polymorphism
Invest. Ophthalmol. Vis. Sci.. 2019; 60(12):3937-3942. doi: https://doi.org/10.1167/iovs.18-25570

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

A bioenergetic crisis in the retinal pigment epithelium contributes to photoreceptor degeneration

Weiyong Shen; Ashish Easow Mathai; Victoria Pye; So-Ra Lee; Michelle X. Yam; Rui Zhang; Ling Zhu; Pankaj Seth; Joshua L Dunaief; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3866. doi:

ARVO Annual Meeting Abstract July 2019

The differential expression of aquaporin-4 (AQP4) in Müller cells from human macular and peripheral retina.

Ling Zhu; Yuyi You; Ting Zhang; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4392. doi:

ARVO Annual Meeting Abstract July 2019

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

SANJEEB BHANDARI; Anne Catherine Biechl; Jennifer Joan Arnold; Stephanie Young; Samanta Fraser-Bell; Hemal Mehta; Mark C Gillies; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2602. doi:

ARVO Annual Meeting Abstract July 2019

Twenty-four month outcomes of inflammatory choroidal neovascularization treated with intravitreal anti vascular endothelial growth factors: a comparison between two treatment regimens

Alessandro Invernizzi; Francesco Pichi; Richard Symes; Sophia Zagora; Vuong Nguyen; Stefano Erba; Alba Xhepa; Luca De Simone; Luca Cimino; Mark C Gillies; Peter J McCluskey

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3859. doi:

ARVO Annual Meeting Abstract July 2019

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Sarah Ah-Moye; Pardis Zalmay; Magnus Theodorsson; Martin Lynn Harris; Riaz Asaria; Adrian Hunt; Daniel Barthelmes; Mark C Gillies; Vuong Nguyen; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4061. doi:

ARVO Annual Meeting Abstract July 2019

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration

Mark C Gillies; SANJEEB BHANDARI; Benjamin Wolff; Jennifer Joan Arnold; Rohan W Essex; Stephanie Young; David M Squirrell; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):111. doi:

ARVO Annual Meeting Abstract July 2019

Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months

Vuong Nguyen; Anagha Vaze; Samanta Fraser-Bell; Jennifer Joan Arnold; Rohan W Essex; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):139. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Extending interoperability in ophthalmology through Fast Healthcare Interoperability Resource (FHIR)

Disruption of the pentose phosphate pathway in Müller cells makes them more susceptible to light stress by interfering with the oxidative stress-induced NRF2 response

JR5558 transgenic mice are a reliable model to investigate subretinal fibrosis

Quality of life impact of eye diseases: a Save Sight Registries study

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Variation in visual outcomes for neovascular age-related macular degeneration within and between practitioners

Comparison of glucose metabolism in human macula and peripheral retina

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Towards retinal regeneration: Reprogramming retinal glial cells into photoreceptors using CRISPRa

PD98059 inhibits the activation of mitogen-activated protein kinase in stressed Müller cells and protects photoreceptor from degeneration

MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus

A bioenergetic crisis in the retinal pigment epithelium contributes to photoreceptor degeneration

The differential expression of aquaporin-4 (AQP4) in Müller cells from human macular and peripheral retina.

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

Twenty-four month outcomes of inflammatory choroidal neovascularization treated with intravitreal anti vascular endothelial growth factors: a comparison between two treatment regimens

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration

Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months

To View More...

You must be signed into an individual account to use this feature.